ADAR1 Capital Management »

Novocure Ltd ord shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Novocure Ltd ord (NVCR) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Novocure Ltd ord

Tip: Access up to 7 years of quarterly data

All positions including Novocure Ltd ord held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novocure Ltd ord by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $827k 64k 12.92

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Novocure Ltd ord

FMR
BlackRock
Vanguard Group
Soleus Capital Management
State Street Corporation
Geode Capital Management
Capital World Investors
Nuveen
Quantinno Capital Management
Millennium Management
Palo Alto Investors
American Century Companies
Ubs Global Asset Management Americas
Baillie Gifford & Co
Renaissance Technologies

View all funds holding Novocure Ltd ord